Yasuo Miyoshi
Nishinomiya-hama, 6638501, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 208 publications
Prognostic significance of peripheral myeloid-derived suppressor cells in advanced breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: October 29, 2025
Identifying immune-related predictive factors for post-eribulin therapy in patients with HER2-negative advanced breast cancer- a multicenter retrospective study.
Journal: International journal of clinical oncology
Published: October 27, 2025
Olanzapine for nausea and vomiting in people with breast cancer treated with trastuzumab deruxtecan: plain language summary of the ERICA study.
Journal: Future oncology (London, England)
Published: October 24, 2025
Pembrolizumab for Early-Stage Triple-Negative Breast Cancer: KEYNOTE-522 Japan Subgroup Analysis.
Journal: Cancer science
Published: September 08, 2025
KEYLYNK-009: Pembrolizumab plus Olaparib in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer after Clinical Benefit from First-Line Pembrolizumab plus Chemotherapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 19, 2025
Targeting Interleukin-6 as a Novel Strategy to Overcome Eribulin Resistance in Breast Cancer.
Journal: Cancer medicine
Published: May 02, 2025
An Acrolein-Based Drug Delivery System Enables Tumor-Specific Sphingosine-1-Phosphate Targeting in Breast Cancer without Lymphocytopenia.
Journal: Cancer research communications
Published: January 16, 2025
Clinical implications of peripheral blood biomarkers in patients with advanced breast cancer treated with trastuzumab emtansine and trastuzumab deruxtecan.
Journal: International journal of clinical oncology
Published: January 10, 2025
Clinical Utility of Sentinel Lymph Node Biopsy Using the Medical Imaging Projection System in Breast Cancer Patients, Including Those Following Neoadjuvant Chemotherapy.
Journal: Anticancer research
Published: January 05, 2025
Radio emissions reveal Alfvénic activity and electron acceleration prior to substorm onset.
Journal: Nature communications
Published: January 03, 2025
Clinical utility of tumor-infiltrating lymphocyte evaluation by two different methods in breast cancer patients treated with neoadjuvant chemotherapy.
Journal: Breast cancer (Tokyo, Japan)
Published: November 04, 2024
Last Updated: 09/26/2026